Marpai (MRAI) Q3 2024 earnings summary

Executive summary

• Net revenues for Q3 2024 were $7.0 million, down 19.7% year-over-year, reflecting customer turnover and ongoing turnaround efforts.

• Net loss for Q3 2024 was $3.6 million, a 51% improvement from $7.3 million in Q3 2023.

• Operating loss for Q3 2024 was $3.1 million, a 56.5% improvement year-over-year.

• Leadership emphasized ongoing turnaround efforts, with the CEO and new institutional investors making direct investments and expressing confidence in long-term value creation.

• The company is exploring strategic alternatives, including potential investment, merger, or sale, to maximize shareholder value.

Financial highlights

• Q3 2024 revenue was $7.0 million, down from $8.7 million in Q3 2023; nine-month revenue fell to $21.6 million.

• Q3 2024 operating expenses were $10.1 million, down 36% year over year.

• Operating loss, excluding a $7.6 million impairment in Q2, improved from $4.7 million to $3.1 million in Q3.

• Cash and cash equivalents at September 30, 2024, were $830 thousand, with negative working capital of $3.3 million.

• Impairment charges of $7.6 million for goodwill and intangible assets were recorded in June 2024.

Outlook and guidance

• Management is seeking additional funding through equity or debt and may scale back operations or divest assets if capital is not secured.

• A robust sales pipeline extends beyond Q1 2025, with new client wins expected to drive growth.

• Major efficiency project underway is expected to reduce TPA expenses by over 25% in Q1 2025.

• Substantial doubt exists about the company's ability to continue as a going concern over the next twelve months.

• Management expects to announce further developments in Q4 and maintains a goal of profitability and positive cash flow.